Clinical Trial Update: Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacology study of VP 20629 in adults with Friedreich's Ataxia has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• VP 20629

Snippet

Sponsor: Shire | Conditions: Friedreich's Ataxia | Phase 1 | Status: COMPLETED | Results posted: 2016-10-06